Physician

Paul Varastad Raphaelian, MD

According to 2025 Medicare claims, Paul Raphaelian, MD (NPI: 1164450201) practices ophthalmology in the Muskegon-Norton Shores, MI market, with the plurality of this provider's patient population coming from Muskegon, MI. This provider's primary affiliated billing organization is ASSOCIATED RETINAL CONSULTANTS, PC (NPI: 1215003793; TIN: 381946761) and primary practice location at 49444-9737.

Raphaelian's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 430 traditional Medicare patients, billed 19,200 HCPCS/CPT codes, and received $1,309,887 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 544 prescription claims across 136 beneficiaries totaling $18,548 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 2 records totaling $17,837. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $2,678,131 to $1,309,887. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.3M$2.7M2015 Medicare payment: $2,678,131 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $2,675,666 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,323,692 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,230,962 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,132,627 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,919,523 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,049,760 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,845,815 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,510,784 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,309,887 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201590714,963$2,678,131
201687114,812$2,675,666
201779312,851$2,323,692
201879112,195$2,230,962
201967410,752$2,132,627
20205828,516$1,919,523
20215229,009$2,049,760
20225038,855$1,845,815
202347112,036$1,510,784
202443019,200$1,309,887

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$34K$67K2015 Drug cost: $27,139 (USD; Tot_Drug_Cst)2016 Drug cost: $25,031 (USD; Tot_Drug_Cst)2017 Drug cost: $24,649 (USD; Tot_Drug_Cst)2018 Drug cost: $27,493 (USD; Tot_Drug_Cst)2019 Drug cost: $67,406 (USD; Tot_Drug_Cst)2020 Drug cost: $21,451 (USD; Tot_Drug_Cst)2021 Drug cost: $25,429 (USD; Tot_Drug_Cst)2022 Drug cost: $23,912 (USD; Tot_Drug_Cst)2023 Drug cost: $24,901 (USD; Tot_Drug_Cst)2024 Drug cost: $18,548 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015132518$27,139
2016137549$25,031
2017137515$24,649
2018137536$27,493
2019127514$67,406
2020129521$21,451
2021150583$25,429
2022152590$23,912
2023156602$24,901
2024136544$18,548

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg70786$654
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more5757$127
67028Injection of drug into eye150759$96
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more3791,076$92
92134Imaging of retina3881,093$29

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1416,974$6,857
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat1067,390$2,086
Ketorolac TromethamineKetorolac Tromethamine451,751$1,255
Brimonidine TartrateBrimonidine Tartrate14754$1,219
LatanoprostLatanoprost1244,755$1,186

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.0$0N/R
Research PaymentsReported research-related payment or transfer-of-value amount.2$17,837Apellis Pharmaceuticals, Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Paul Varastad Raphaelian, MD?

Tedicare shows public-source Medicare data for Paul Varastad Raphaelian, MD (NPI 1164450201), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Paul Varastad Raphaelian, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Paul Varastad Raphaelian, MD?

Paul Varastad Raphaelian, MD is linked to ASSOCIATED RETINAL CONSULTANTS, PC (billing NPI 1215003793) in the available physician profile data.

Does Paul Varastad Raphaelian, MD have Open Payments data?

Paul Varastad Raphaelian, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.